Corvus Pharmaceuticals Inc. (CRVS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Corvus Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.52
−0.19% today
Market cap
$887M
Overall quality
50/100
Kronos AI 30-day
+16.2%
8 of 8 simulated paths end higher
Corvus Pharmaceuticals Inc. (CRVS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $887M. It trades at $10.52, down 0.19% today. Its overall quality score is 50 out of 100, ranked against the whole US market. 4 analysts' average target of $29.50 implies +180.4% from today's price. Kronos AI's 30-day forecast is +16.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $29.50 |
| Low – high | $27.00 – $33.00 |
| Analysts | 4 |
| Upside to average | +180.4% |
Kronos AI 30-day forecast
| Expected close | $12.24 (+16.2%) |
| Likely range | +11.8% … +42.8% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 41 |
| Solvency | 57 |
| Growth | 51 |
| Overall | 50 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.